LIST OF TABLES

Table 1 Renal Disease Industry Synopsis, 2023-2032
Table 2 Global Renal Disease Market Estimates and Forecast, 2023-2032, (USD Million)
Table 3 Global Renal Disease Market, by Region, 2023-2032, (USD Million)
Table 4 Global Renal Disease Market, by Diagnosis, 2023-2032, (USD Million)
Table 5 Global Renal Disease Market, by Treatment, 2023-2032, (USD Million)
Table 6 Global Renal Disease Market, by Indication, 2023-2032, (USD Million)
Table 7 Global Renal Disease Market, by End-User, 2023-2032, (USD Million)
Table 8 North America Renal Disease Market, by Diagnosis, 2023-2032, (USD Million)
Table 9 North America Renal Disease Market, by Treatment, 2023-2032, (USD Million)
Table 10 North America Renal Disease Market, by Indication, 2023-2032, (USD Million)
Table 11 North America Renal Disease Market, by End-User, 2023-2032, (USD Million)
Table 12 US Renal Disease Market, by Diagnosis, 2023-2032, (USD Million)
Table 13 US Renal Disease Market, by Treatment, 2023-2032, (USD Million)
Table 14 US Renal Disease Market, by Indication, 2023-2032, (USD Million)
Table 15 US Renal Disease Market, by End-User, 2023-2032, (USD Million)
Table 16 Canada Renal Disease Market, by Diagnosis, 2023-2032, (USD Million)
Table 17 Canada Renal Disease Market, by Treatment, 2023-2032, (USD Million)
Table 18 Canada Renal Disease Market, by Indication, 2023-2032, (USD Million)
Table 19 Canada Renal Disease Market, by End-User, 2023-2032, (USD Million)
Table 20 South America Renal Disease Market, by Diagnosis, 2023-2032, (USD Million)
Table 21 South America Renal Disease Market, by Treatment, 2023-2032, (USD Million)
Table 22 South America Renal Disease Market, by Indication, 2023-2032, (USD Million)
Table 23 South America Renal Disease Market, by End-User, 2023-2032, (USD Million)
Table 24 Europe Renal Disease Market, by Diagnosis, 2023-2032, (USD Million)
Table 25 Europe Renal Disease Market, by Treatment, 2023-2032, (USD Million)
Table 26 Europe Renal Disease Market, by Indication, 2023-2032, (USD Million)
Table 27 Europe Renal Disease Market, by End-User, 2023-2032, (USD Million)
Table 28 Western Europe Renal Disease Market, by Diagnosis, 2023-2032, (USD Million)
Table 29 Western Europe Renal Disease Market, by Treatment, 2023-2032, (USD Million)
Table 30 Western Europe Renal Disease Market, by Indication, 2023-2032, (USD Million)
Table 31 Western Europe Renal Disease Market, by End-User, 2023-2032, (USD Million)
Table 32 Eastern Europe Renal Disease Market, by Diagnosis, 2023-2032, (USD Million)
Table 33 Eastern Europe Renal Disease Market, by Treatment, 2023-2032, (USD Million)
Table 34 Eastern Europe Renal Disease Market, by Indication, 2023-2032, (USD Million)
Table 35 Eastern Europe Renal Disease Market, by End-User, 2023-2032, (USD Million)
Table 36 Asia Pacific Renal Disease Market, by Diagnosis, 2023-2032, (USD Million)
Table 37 Asia Pacific Renal Disease Market, by Treatment, 2023-2032, (USD Million)
Table 38 Asia Pacific Renal Disease Market, by Indication, 2023-2032, (USD Million)
Table 39 Asia Pacific Renal Disease Market, by End-User, 2023-2032, (USD Million)
Table 40 Middle East & Africa Renal Disease Market, by Diagnosis, 2023-2032, (USD Million)
Table 41 Middle East & Africa Renal Disease Market, by Treatment, 2023-2032, (USD Million)
Table 42 Middle East & Africa Renal Disease Market, by Indication, 2023-2032, (USD Million)
Table 43 Middle East & Africa Renal Disease Market, by End-User, 2023-2032, (USD Million)

LIST OF FIGURES

Figure 1 Research Process
Figure 2 Segmentation for Global Renal Disease Market
Figure 3 Segmentation Market Dynamics for Renal Disease Market
Figure 4 Global Renal Disease Market Share, by Treatment, 2020
Figure 5 Global Renal Disease Market Share, by Indication, 2020
Figure 6 Global Renal Disease Market Share, by End-User, 2020
Figure 7 Global Renal Disease Market Share, by Region, 2020
Figure 8 North America Renal Disease Market Share, by Country, 2020
Figure 9 Europe Renal Disease Market Share, by Country, 2020
Figure 10 Asia Pacific Renal Disease Market Share, by Country, 2020
Figure 11 Middle East & Africa Renal Disease Market Share, by Country, 2020
Figure 12 Global Renal Disease Market: Company Share Analysis, 2020 (%)
Figure 13 Abbott: Key Financials
Figure 14 Abbott: Segmental Revenue
Figure 16 Abbott: Geographical Revenue
Figure 17 Amgen Inc. : Key Financials
Figure 18 Amgen Inc. : Segmental Revenue
Figure 19 Amgen Inc. : Geographical Revenue
Figure 20 AstraZeneca : Key Financials
Figure 21 AstraZeneca : Segmental Revenue
Figure 22 AstraZeneca : Geographical Revenue
Figure 23 Hoffmann-La Roche Ltd: Key Financials
Figure 24 Hoffmann-La Roche Ltd: Segmental Revenue
Figure 25 Hoffmann-La Roche Ltd: Geographical Revenue
Figure 26 GlaxoSmithKline PLC : Key Financials
Figure 27 GlaxoSmithKline PLC : Segmental Revenue
Figure 28 GlaxoSmithKline PLC : Geographical Revenue
Figure 29 Kissei Pharmaceutical Co., Ltd. .: Key Financials
Figure 30 Kissei Pharmaceutical Co., Ltd. : Segmental Revenue
Figure 31 Kissei Pharmaceutical Co., Ltd. : Geographical Revenue